Different chemical strategies have been employed for labelling biotin using 188Re with the aim to develop a sterile and pyrogen free kit formulation that is suitable for clinical use. A number of biotin conjugated 188Re complexes were prepared and evaluated to determine their affinity for avidin. The most difficult challenge was to devise an efficient reaction pathway that was able to obtain the final radiocompounds in a high radiochemical yield. This work describes the molecular design and the chemical strategy that were followed to obtain reliable preparation of the new radiopharmaceuticals starting from generator produced [188ReO4]–
The favorable nuclear properties of rhenium-188 for therapeutic application are described, together ...
Four 99mTc-MAG3-biotin conjugates were synthesized to determine their potential use in antibody pret...
This grant was a one-year extension of another grant with the same title (DE-FG03-98ER62572). The ob...
linking were realized to the lyophilized product quality control tests like: stability and radiochem...
The aim of this work was to develop an easy-to-use kit formulation for the high-yield preparation of...
The synthesis of four biotin derivatives carrying two DOTA moieties for each ligand (BisDOTA set) is...
This study focuses on the design, development, and synthesis of technetium and rhenium radiopharmace...
Chemical modifications of the biotin carrier in pretargeted avidin-biotin radionuclide therapy may b...
After a lull in development of new chemistry for rhenium-188 and technetium-99m since 2000, there ha...
Chemical modifications of the biotin carrier in pretargeted avidin-biotin radionuclide therapy may b...
grantor: University of TorontoA solid phase labelling process was developed to produce a n...
1. INTRODUCTION Rhenium-188 is a promising radionuclide for radiotherapeutic applications. It emits ...
Aim. Radionuclide therapy still remains one of the potentially most effective approaches for the tre...
OBJECTIVES: Biocytin analogues labelled with indium-111, yttrium-90 and lutetium-177 have shown thei...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
The favorable nuclear properties of rhenium-188 for therapeutic application are described, together ...
Four 99mTc-MAG3-biotin conjugates were synthesized to determine their potential use in antibody pret...
This grant was a one-year extension of another grant with the same title (DE-FG03-98ER62572). The ob...
linking were realized to the lyophilized product quality control tests like: stability and radiochem...
The aim of this work was to develop an easy-to-use kit formulation for the high-yield preparation of...
The synthesis of four biotin derivatives carrying two DOTA moieties for each ligand (BisDOTA set) is...
This study focuses on the design, development, and synthesis of technetium and rhenium radiopharmace...
Chemical modifications of the biotin carrier in pretargeted avidin-biotin radionuclide therapy may b...
After a lull in development of new chemistry for rhenium-188 and technetium-99m since 2000, there ha...
Chemical modifications of the biotin carrier in pretargeted avidin-biotin radionuclide therapy may b...
grantor: University of TorontoA solid phase labelling process was developed to produce a n...
1. INTRODUCTION Rhenium-188 is a promising radionuclide for radiotherapeutic applications. It emits ...
Aim. Radionuclide therapy still remains one of the potentially most effective approaches for the tre...
OBJECTIVES: Biocytin analogues labelled with indium-111, yttrium-90 and lutetium-177 have shown thei...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
The favorable nuclear properties of rhenium-188 for therapeutic application are described, together ...
Four 99mTc-MAG3-biotin conjugates were synthesized to determine their potential use in antibody pret...
This grant was a one-year extension of another grant with the same title (DE-FG03-98ER62572). The ob...